Serum Ischemia-Modified Albumin Levels, Myeloperoxidase Activity and Peripheral Blood Mononuclear cells in Autism Spectrum Disorder (ASD)
暂无分享,去创建一个
[1] Y. Bozzi,et al. Oxidative Stress and Immune System Dysfunction in Autism Spectrum Disorders , 2020, International journal of molecular sciences.
[2] R. Kizek,et al. Oxidative Stress in Autism Spectrum Disorder , 2020, Molecular Neurobiology.
[3] P. Gorczyca,et al. Autism spectrum disorder (ASD) - biomarkers of oxidative stress and methylation and transsulfuration cycle. , 2019, Psychiatria polska.
[4] P. Crack,et al. The influence of neuroinflammation in Autism Spectrum Disorder , 2019, Brain, Behavior, and Immunity.
[5] S. Neşelioğlu,et al. Ischemia-modified albumin: a unique marker of global metabolic risk in schizophrenia and mood disorders , 2018, Psychiatry and Clinical Psychopharmacology.
[6] A. Switala,et al. Neuroimmunologic and Neurotrophic Interactions in Autism Spectrum Disorders: Relationship to Neuroinflammation , 2018, NeuroMolecular Medicine.
[7] A. Rahmani,et al. Myeloperoxidase as an Active Disease Biomarker: Recent Biochemical and Pathological Perspectives , 2018, Medical sciences.
[8] M. Ceylan,et al. High monocyte level and low lymphocyte to monocyte ratio in autism spectrum disorders , 2017, International journal of developmental disabilities.
[9] M. Pejović-Milovančević,et al. Impaired Redox Control in Autism Spectrum Disorders: Could It Be the X in GxE? , 2017, Current Psychiatry Reports.
[10] Pascual-leoneAlvaro,et al. Abnormal Mechanisms of Plasticity and Metaplasticity in Autism Spectrum Disorders and Fragile X Syndrome. , 2016 .
[11] E. Vasar,et al. Antipsychotic Treatment Reduces Indices of Oxidative Stress in First-Episode Psychosis Patients , 2016, Oxidative medicine and cellular longevity.
[12] Y. Arslan,et al. Assessment of the role of serum ischemia-modified albumin in obstructive sleep apnea in comparison with interleukin-6 , 2016, Postgraduate medicine.
[13] Maureen S. Durkin,et al. Prevalence and Characteristics of Autism Spectrum Disorder Among 4-Year-Old Children in the Autism and Developmental Disabilities Monitoring Network , 2016, Journal of developmental and behavioral pediatrics : JDBP.
[14] Christine Ecker,et al. Neuroimaging in autism spectrum disorder: brain structure and function across the lifespan , 2015, The Lancet Neurology.
[15] B. Dale,et al. Link Between Increased Prevalence of Autism Spectrum Disorder Syndromes and Oxidative Stress, DNA Methylation, and Imprinting: The Impact of the Environment. , 2015, JAMA pediatrics.
[16] S. Selek,et al. Oxidative markers of Myeloperoxidase and Catalase and their diagnostic performance in bipolar disorder. , 2015, Journal of affective disorders.
[17] R. Huganir,et al. Glutamate synapses in human cognitive disorders. , 2015, Annual review of neuroscience.
[18] A. Nagar,et al. Corrigendum to "A quantum theory for the irreplaceable role of docosahexaenoic acid in neural cell signalling throughout evolution" Prostaglandins Leukot. Essent. Fatty Acids 88(1) (2013) 5-13 , 2014 .
[19] M. Ceylan,et al. Increased levels of serum neopterin in attention deficit/hyperactivity disorder (ADHD) , 2014, Journal of Neuroimmunology.
[20] Michel Botbol,et al. Gene × Environment Interactions in Autism Spectrum Disorders: Role of Epigenetic Mechanisms , 2014, Front. Psychiatry.
[21] E. Eren,et al. Ischemia-Modified Albumin: Could It Be a New Oxidative Stress Biomarker for Colorectal Carcinoma? , 2013, Gut and liver.
[22] Janet B W Williams. Diagnostic and Statistical Manual of Mental Disorders , 2013 .
[23] G. B. Schaefer,et al. Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions , 2013, Genetics in Medicine.
[24] P. Ashwood,et al. Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment. , 2013, Neurotoxicology and teratology.
[25] M. Ceylan,et al. Changes in oxidative stress and cellular immunity serum markers in attention‐deficit/hyperactivity disorder , 2012, Psychiatry and clinical neurosciences.
[26] D. Rossignol,et al. A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures , 2011, Molecular Psychiatry.
[27] Y. S. Kim,et al. Prevalence of autism spectrum disorders in a total population sample. , 2011, The American journal of psychiatry.
[28] E. Walker,et al. Diagnostic and Statistical Manual of Mental Disorders , 2013 .
[29] Inbal Goshen,et al. Immune modulation of learning, memory, neural plasticity and neurogenesis , 2011, Brain, Behavior, and Immunity.
[30] B. Jepson,et al. Low serum myeloperoxidase in autistic children with gastrointestinal disease , 2009, Clinical and experimental gastroenterology.
[31] V. Vaccarino,et al. Association of Major Depressive Disorder with Serum Myeloperoxidase and Other Markers of Inflammation: A Twin Study , 2008, Biological Psychiatry.
[32] Barry Halliwell,et al. Oxidative stress and neurodegeneration: where are we now? , 2006, Journal of neurochemistry.
[33] A. Zimmerman,et al. Neuroglial activation and neuroinflammation in the brain of patients with autism , 2005, Annals of neurology.
[34] C. McDougle,et al. High blood monocyte counts and neopterin levels in children with autistic disorder. , 2003, The American journal of psychiatry.
[35] Marie-Luise Brennan,et al. Myeloperoxidase Functions as a Major Enzymatic Catalyst for Initiation of Lipid Peroxidation at Sites of Inflammation* , 2002, The Journal of Biological Chemistry.
[36] D. Bar-Or,et al. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. , 2000, The Journal of emergency medicine.
[37] D. Guilloteau,et al. Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats. , 1994, The Journal of nutrition.
[38] D. Priebat,et al. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. , 1982, The Journal of investigative dermatology.
[39] E. Schopler,et al. Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS) , 1980, Journal of autism and developmental disorders.
[40] M. Cline,et al. Monocytes, macrophages, and their diseases in man. , 1978, The Journal of investigative dermatology.
[41] J. Melnick,et al. Congenital rubella encephalitis. Effects on growth and early development. , 1969, American journal of diseases of children.
[42] Luc Lecavalier,et al. Childhood Autism Rating Scale , 2021, Encyclopedia of Autism Spectrum Disorders.
[43] Judy Van de Water,et al. The Role of the Immune System in Autism Spectrum Disorder , 2017, Neuropsychopharmacology.
[44] Á. Pascual-Leone,et al. Abnormal Mechanisms of Plasticity and Metaplasticity in Autism Spectrum Disorders and Fragile X Syndrome. , 2016, Journal of child and adolescent psychopharmacology.
[45] M. Carter. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. , 2014 .
[46] E. Nunez. Preface--fatty acids and cell signalling. , 1993, Prostaglandins, leukotrienes, and essential fatty acids.
[47] S. Chess,et al. Autism in children with congenital rubella , 1971, Journal of autism and childhood schizophrenia.